DPP-4i

DRUG2 trials

Sponsors

University of Campania Luigi Vanvitelli, Boehringer Ingelheim

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Unknown Phase

Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)

CompletedNCT03918148

University of Campania Luigi VanvitelliType 2 Diabetes Mellitus

Start: 2018-01-15End: 2023-12-31Updated: 2024-04-19

A Study Based on Data From German Sick Funds That Looks at the Costs of Treatment of Type-2 Diabetic Patients With Empagliflozin vs. DPP-4 Inhibitors vs. GLP-1 Receptor Agonists

CompletedNCT04295005

Boehringer IngelheimDiabetes Mellitus, Type 2

Start: 2020-11-16End: 2021-09-30Updated: 2024-08-30